...
首页> 外文期刊>Environmental research >Bisphenol A exposure in relation to altered lipid profile and dyslipidemia among Chinese adults: A repeated measures study
【24h】

Bisphenol A exposure in relation to altered lipid profile and dyslipidemia among Chinese adults: A repeated measures study

机译:双酚是在中国成人中改变脂质剖面和血脂血症的接触:重复措施研究

获取原文
获取原文并翻译 | 示例
           

摘要

Animal experiments suggest that bisphenol A (BPA) could potentially induce lipid abnormalities. However, whether BPA exposure associates with altered lipid metabolism in humans has not been fully elucidated. We thus comprehensively investigated the relationship of BPA exposure and its change with lipid profile and development of incident dyslipidemia among Chinese adults. We initially included 1872 participants aged 40 years or older who were free of dyslipidemia at baseline in 2009, and followed them for 4 years. Urinary BPA and serum lipids including total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG) were determined at baseline and follow-up. Linear mixed models were used for repeated measures analyses and linear and logistic regression models were used to evaluate longitudinal changes in lipid profile and risk of incident dyslipidemia. In repeated measures analyses, per doubling of urinary BPA concentrations was associated with higher serum levels of LDL-C, non-HDL-C, TC to HDL-C ratio, and lower levels of HDL-C and TG. In longitudinal change analyses, participants with high BPA at both baseline and follow-up showed an additional 2.94% increase in LDL-C (95% CI: 0.02%, 5.95%) and 6.12% increase in TG (95% CI: 0.74%, 11.8%), as compared with those who maintained low BPA. Furthermore, participants with sustained high BPA at two time points had increased odds of developing hyper-LDL cholester-olemia (odds ratio = 1.93, 95% CI: 1.02, 3.66). Our results suggested that high BPA exposure, especially maintained a long time period apart, was associated with deterioration of lipid profiles among middle-aged and elderly adults, supporting a detrimental role of BPA in lipid metabolism.
机译:动物实验表明,双酚A(BPA)可能会诱导脂质异常。然而,BPA暴露伴侣是否患有改变的人类在人体中的脂质代谢均未得到完全阐明。因此,我们全面调查了BPA暴露的关系及其在中国成人中血脂剖面和事件血脂血症的发展。我们最初包含1872岁或以上的参与者,2009年在基线上没有血脂血症,并遵循它们4年。在基线和随访中测定包括总胆固醇(Tc),低密度脂蛋白胆固醇(LDL-C),高密度脂蛋白胆固醇(HDL-C),高密度脂蛋白胆固醇(HDL-C)和甘油三酯(TG)的尿BPA和血清脂质。线性混合模型用于重复措施分析和线性和逻辑回归模型用于评估脂质型材的纵向变化和入射血脂血症的风险。在反复措施分析中,每次尿BPA浓度与较高的LDL-C,非HDL-C,TC与HDL-C比率相关,以及低水平的HDL-C和Tg。在纵向变化分析中,基线和随访中具有高BPA的参与者表现出LDL-C(95%CI:0.02%,5.95%)增加2.94%(95%Ci:0.02%,5.95%)和6.12%(95%Ci:0.74%)与那些维持低BPA的人相比,11.8%。此外,在两个时间点的持续高BPA的参与者增加了高LDL胆固醇 - 烯脲的几率(差距= 1.93,95%CI:1.02,3.66)。我们的研究结果表明,高BPA暴露,特别是保持长时间的时间,与中年和老年人的脂质曲线的恶化有关,支持BPA在脂质代谢中的有害作用。

著录项

  • 来源
    《Environmental research》 |2020年第5期|109382.1-109382.8|共8页
  • 作者单位

    State Key Laboratory of Medical Genomics Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health National Clinical Research Center for Metabolic Diseases Department of Endocrine and Metabolic Diseases Shanghai Institute of Endocrine and Metabolic Diseases Rui-Jin Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200025 China;

    State Key Laboratory of Medical Genomics Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health National Clinical Research Center for Metabolic Diseases Department of Endocrine and Metabolic Diseases Shanghai Institute of Endocrine and Metabolic Diseases Rui-Jin Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200025 China;

    State Key Laboratory of Medical Genomics Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health National Clinical Research Center for Metabolic Diseases Department of Endocrine and Metabolic Diseases Shanghai Institute of Endocrine and Metabolic Diseases Rui-Jin Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200025 China;

    State Key Laboratory of Medical Genomics Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health National Clinical Research Center for Metabolic Diseases Department of Endocrine and Metabolic Diseases Shanghai Institute of Endocrine and Metabolic Diseases Rui-Jin Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200025 China;

    State Key Laboratory of Medical Genomics Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health National Clinical Research Center for Metabolic Diseases Department of Endocrine and Metabolic Diseases Shanghai Institute of Endocrine and Metabolic Diseases Rui-Jin Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200025 China;

    State Key Laboratory of Medical Genomics Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health National Clinical Research Center for Metabolic Diseases Department of Endocrine and Metabolic Diseases Shanghai Institute of Endocrine and Metabolic Diseases Rui-Jin Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200025 China;

    State Key Laboratory of Medical Genomics Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health National Clinical Research Center for Metabolic Diseases Department of Endocrine and Metabolic Diseases Shanghai Institute of Endocrine and Metabolic Diseases Rui-Jin Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200025 China;

    State Key Laboratory of Medical Genomics Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health National Clinical Research Center for Metabolic Diseases Department of Endocrine and Metabolic Diseases Shanghai Institute of Endocrine and Metabolic Diseases Rui-Jin Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200025 China;

    State Key Laboratory of Medical Genomics Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health National Clinical Research Center for Metabolic Diseases Department of Endocrine and Metabolic Diseases Shanghai Institute of Endocrine and Metabolic Diseases Rui-Jin Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200025 China;

    State Key Laboratory of Medical Genomics Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health National Clinical Research Center for Metabolic Diseases Department of Endocrine and Metabolic Diseases Shanghai Institute of Endocrine and Metabolic Diseases Rui-Jin Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200025 China;

    State Key Laboratory of Medical Genomics Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health National Clinical Research Center for Metabolic Diseases Department of Endocrine and Metabolic Diseases Shanghai Institute of Endocrine and Metabolic Diseases Rui-Jin Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200025 China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Bisphenol A; Lipid metabolism; Longitudinal change; Repeated measures; Dyslipidemia;

    机译:双酚A;脂质代谢;纵向变化;重复措施;血脂血症;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号